Sex differences in antiplatelet response in ischemic stroke

Women's Health

Volumn 7, Issue 4, 2011, Pages 465-474

  Meyer, Dawn M ^a   Eastwood, Jo Ann ^b   Compton, Margaret P ^b   Gylys, Karen ^b   Zivin, Justin A ^a   Ovbiagele, Bruce ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acute stroke treatment; antiplatelet; antithrombotic; aspirin; cerebral ischemia; cilostazol; clinical trials; clopidogrel; coagulation; dipyridamole; estrogen; gender; hormones; ischemic stroke; prognosis; sex differences; stroke prevention; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; CLOPIDOGREL; ESTROGEN; PLACEBO; PROGESTERONE; THROMBOCYTE RECEPTOR; WARFARIN;

ACUTE DISEASE; ANTICOAGULATION; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CELL EXPANSION; CONCEPTUAL FRAMEWORK; DRUG MECHANISM; DRUG RESPONSE; HEART INFARCTION; HORMONE ACTION; HUMAN; INJURY SEVERITY; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SEX DIFFERENCE; STROKE; THROMBOCYTE ACTIVATION; THROMBOGENESIS; TRAUMATIC BRAIN INJURY;

ANTICOAGULANTS; BRAIN ISCHEMIA; CEREBROVASCULAR DISORDERS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 79960958061     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.11.45     Document Type: Review

References (44)

1. Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 123(4), E18-E209 (2011).
2. Rosamond W, Flegal K, Furie K et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 117(4), E25-E146 (2008).
3. Ovbiagele B. National Sex-specific trends in hospital-based stroke rates. J. Stroke Cerebrovasc. Dis. (2010) (Epub ahead of print).
4. Arnold M, Halpern M, Meier Net al. Age-dependent differences in demographics, risk factors, co-morbidity, etiology, management, and clinical outcome of acute ischemic stroke. J. Neurol. 255(10), 1503-1507 (2008).
5. Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 119(3), E21-E181 (2009).
6. Roquer J, Campello AR, Gomis M. Sex differences in first-ever acute stroke. Stroke 34(7), 1581-1585 (2003) (Pubitemid 36842605)
7. Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV. Sex differences and similarities in the management and outcome of stroke patients. Stroke 31(8), 1833-1837 (2000). (Pubitemid 30620459)
8. Kapral MK, Devon J, Winter AL, Wang J, Peters A, Bondy SJ. Gender differences in stroke care decision-making. Med. Care 44(1), 70-80 (2006). (Pubitemid 43755482)
9. Niewada M, Kobayashi A, Sandercock PAG, Kaminski B, Czlonkowska A. Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology 24(3), 123-128 (2005). (Pubitemid 41094837)
10. Anderson GL, Limacher M, Assaf AR et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The women's health initiative randomized controlled trial. JAMA 291(14), 1701-1712 (2004). (Pubitemid 38489892)
11. Grodstein F, Manson JE, Stampfer MJ, Rexrode K. Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch. Intern. Med. 168(8), 861-866 (2008). (Pubitemid 351620088)
12. Clemetson KJ, Clemetson JM. Platelet Receptors. In:Platelets (2nd Edition).Michelson AD (Ed.).Elsevier, CA, USA, 117-144 (2007).
13. Monroe DM, Hoffman M. What does it take to make the perfect clot? Arterioscler. Thromb. Vasc. Biol. 26(1), 41-48 (2006). (Pubitemid 43732226)
14. Bouchard BA, Butenas S, Mann KG, Tracy PB. Interactions Between Platelets and the Coagulation System. In:Platelets (2nd Edition).Michelson AD (Ed.).Academic Press, CA, USA, 377-402 (2006).
15. Venes D. Tabers Cyclopedic Medical Dictionary (20th Edition).Venes D (Ed).FA Davis Company, PA, USA (2005).
16. Merriam-Webster Collegiate Dictionary (11th Edition).Merriam-Webster, MA, USA (2003).
17. Goroll AH, Mulley Jr AG. Gynecologic Problems. In:Primary Care Medicine (4th Edition). Goroll AH, Mulley AG Jr (Eds).Lippincott, Williams & Wilkins PA, USA, 667-738 (1995).
18. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol. Rev. 60(2), 210-241 (2008). (Pubitemid 351962010)
19. Miller VM, Jayachandran M, Hashimoto K, Heit JA, Owen WG. Estrogen, inflammation, and platelet phenotype. Gend. Med. 5(Suppl. A), S91-S102 (2008).
20. Rossouw JE, Anderson GL, Prentice RL et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288(3), 321-333 (2002). (Pubitemid 34761611)
21. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).Lancet 348(9038), 1329-1339 (1996).
22. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J. Neurol. Sci. 143(1-2), 1-13 (1996). (Pubitemid 26402780)
23. International Stroke Trial Collaborative Group. The international stroke trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349, 1569-1581 (1997).
24. Stampfer MJ, Colditz GA, Willett WC et al. Postmenopausal Estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N. Engl. J. Med. 325(11), 756-762 (1991).
25. Cook NR, Lee IM, Gaziano JM et al. Low-dose aspirin in the primary prevention of cancer. JAMA 294(1), 47-55 (2005).
26. Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308, 81-98 (1994).
27. Sacco RL, Adams R, Albers G et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/ American Stroke Association council on stroke: co-sponsored by the council on cardiovascular radiology and intervention: the American academy of neurology affirms the value of this guideline. Stroke 37(2), 577-617 (2006). (Pubitemid 43732031)
28. Chiang N, Hurwitz S, Ridker PM, Serhan CN. Aspirin has a gender-dependent impact on anti-inflammatory 15-epi-lipoxin A4 formation: a randomized human trial. Arterioscler. Thromb. Vasc. Biol. 26(2), e14-e17 (2006). (Pubitemid 43732186)
29. Cavallari LH, Helgason CM, Brace LD, Viana MA, Nutescu EA. Sex difference in the antiplatelet effect of aspirin in patients with stroke. Ann. Pharmacother. 40(5), 812-817 (2006). (Pubitemid 43764997)
30. Grotemeyer KH, Scharafinski HW, Husstedt IW. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb. Res. 71(5), 397-403 (1993).
31. Chen W-H, Cheng X, Lee P-Y et al. Aspirin resistance and adverse clinical events in patients with coronary artery disease. Am. J. Med. 120(7), 631-635 (2007). (Pubitemid 46977320)
32. Lisabeth LD, Roychoudhury C, Brown DL, Levine SR. Do gender and race impact the use of antithrombotic therapy in patients with stroke/TIA? Neurology 62(12), 2313-2315 (2004). (Pubitemid 38787798)
33. Del Sette M. Migraine and cerebrovascular risk. Neurol. Sci. 31(Suppl. 1), S127-S128 (2010).
34. Nightingale A, Farmer R. Ischemic stroke in young women: a nested case-controlled study using the UK general practice research database. Stroke (35), 1574-1578 (2004). (Pubitemid 38823627)
35. Levine SR, Brey RL, Tilley BC et al. APASS investigators. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 291(5), 576-584 (2004). (Pubitemid 38500311)
36. Furie KL, Kasner SE, Adams RJ et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 42(1), 227-276 (2011).
37. Arnold A, Burgoyne P. Are XX and XY brain cells intrinsically different? Trends Endocrinol. Metab. 15(1), 6-11 (2004). (Pubitemid 38198093)
38. Heyer A, Hasselblatt M, von Ahsen N, Hafner H, Siren A-L, Ehrenreich H. In vitro gender differences in neuronal survival on hypoxia and in 17[β]-estradiol-mediated neuroprotection. J. Cereb. Blood Flow Metab. 25(4), 427-433 (2005).
39. Gibson CL, Gray LJ, Bath PMW, Murphy SP. Progesterone for the treatment of experimental brain injury; a systematic review. Brain 131(2), 318-328 (2008). (Pubitemid 351197603)
40. Gibson CL, Constantin D, Prior MJW, Bath PMW, Murphy SP. Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp. Neurol. 193(2), 522-531 (2005).
41. Sunday L, Tran MM, Krause DN, Duckles SP. Estrogen and progestagens differentially modulate vascular proinflammatory factors. Am. J. Physiol. Endocrinol. Metab. 291(2), E261-E267 (2006). (Pubitemid 44035284)
42. Wright DW, Kellermann AL, Hertzberg VS et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med. 49(4), 391 (2007).
43. Butenas S, vaǹt Veer C, Mann KG. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J. Biol. Chem. 272(34), 21527-21533 (1997). (Pubitemid 27374027)
44. Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb. Haemost. 85(6), 958-965 (2001). (Pubitemid 32573743)